Security: Series D Preferred

President & CEO: Richard Daly

New Investors: Primus
Existing Investors: Chrysalis Ventures, Undisclosed Investor, Oxford Bioscience Partners, Marathon, Fort Washington Private Equity, Hillside Capital Management

Board of Directors: Jonathan Fleming, David Jones, Jack Davis, Richard Daly, Keith Kerman

- Acquisition financing by private equity firm.

- Reengaged Aquilo Partners after successful Series B preferred stock and debt financing in March 2007.

- Total raised by Aquilo Partners for Laboratory Partners in 2007 was $69m.